Teva Pharmaceutical Industries

Sustainability Report and Carbon Intensity Rankings

Is Teva Pharmaceutical Industries doing their part?

Their DitchCarbon score is 43

Teva Pharmaceutical Industries has a DitchCarbon Score of 43 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity level, suggesting there is significant room for improvement in reducing emissions. To enhance its sustainability efforts, Teva should focus on strategies to lower its carbon intensity and move towards more environmentally friendly operations.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Teva Pharmaceutical Industries operates within the industrial manufacturing sector, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Teva Pharmaceutical Industries, located in a region with a low carbon intensity rating, benefits from a cleaner energy grid. This advantageous location supports the company’s sustainability efforts by reducing its overall carbon footprint in comparison to regions with higher carbon intensity.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Teva Pharmaceutical Industries

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

1.71%

...this company is doing 1.71% better in emissions than the industry average.

Teva Pharmaceutical Industries, founded in 1901, is a prominent player in the global pharmaceutical industry, headquartered in Israel. Specializing in both generic and specialty medicines, Teva offers an extensive portfolio of over 3,500 products across various therapeutic areas. The company’s vast supply chain reaches around 200 million people worldwide, underscoring its commitment to improving health and accessibility to medications.

Bad news, Teva Pharmaceutical still hasn't committed to SBTi goals.

Teva Pharmaceutical Industries has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not defined or announced clear goals for reducing greenhouse gas emissions in line with climate science.
Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.